These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. PEITC inhibits human brain glioblastoma GBM 8401 cell migration and invasion through the inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and -9 gene expression. Chou YC; Chang MY; Wang MJ; Yu FS; Liu HC; Harnod T; Hung CH; Lee HT; Chung JG Oncol Rep; 2015 Nov; 34(5):2489-96. PubMed ID: 26352173 [TBL] [Abstract][Full Text] [Related]
5. Anti-Migration and Invasion Effects of Astaxanthin against A172 Human Glioblastoma Cell Line. Siangcham T; Vivithanaporn P; Sangpairoj K Asian Pac J Cancer Prev; 2020 Jul; 21(7):2029-2033. PubMed ID: 32711429 [TBL] [Abstract][Full Text] [Related]
6. The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field. Hoxha M; Rovati GE; Cavanillas AB Eur J Clin Pharmacol; 2017 Jul; 73(7):799-809. PubMed ID: 28374082 [TBL] [Abstract][Full Text] [Related]
7. Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine. Zhang FY; Hu Y; Que ZY; Wang P; Liu YH; Wang ZH; Xue YX Int J Mol Sci; 2015 Oct; 16(10):23823-48. PubMed ID: 26473829 [TBL] [Abstract][Full Text] [Related]
8. Neuromodulatory effects of leukotriene receptor antagonists: A comprehensive review. Sood R; Anoopkumar-Dukie S; Rudrawar S; Hall S Eur J Pharmacol; 2024 Sep; 978():176755. PubMed ID: 38909933 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms underlying the protective effect of leukotriene receptor antagonist montelukast against doxorubicin induced testicular injury in rats. Mohamed MZ; Zenhom NM Prostaglandins Other Lipid Mediat; 2020 Aug; 149():106447. PubMed ID: 32173485 [TBL] [Abstract][Full Text] [Related]
11. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice. Yu GL; Wei EQ; Zhang SH; Xu HM; Chu LS; Zhang WP; Zhang Q; Chen Z; Mei RH; Zhao MH Pharmacology; 2005 Jan; 73(1):31-40. PubMed ID: 15452361 [TBL] [Abstract][Full Text] [Related]
12. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Shimbori C; Shiota N; Okunishi H Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736 [TBL] [Abstract][Full Text] [Related]
13. Leukotriene Receptor Antagonists Inhibit Mitogenic Activity in Triple Negative Breast Cancer Cells. Suknuntha K; Yubolphan R; Krueaprasertkul K; Srihirun S; Sibmooh N; Vivithanaporn P Asian Pac J Cancer Prev; 2018 Mar; 19(3):833-837. PubMed ID: 29582642 [TBL] [Abstract][Full Text] [Related]
15. Effect of a specific cysteinyl leukotriene-receptor 1-antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells. Virchow JC; Faehndrich S; Nassenstein C; Bock S; Matthys H; Luttmann W Clin Exp Allergy; 2001 Jun; 31(6):836-44. PubMed ID: 11422147 [TBL] [Abstract][Full Text] [Related]